AUPH

Aurinia Pharmaceuticals Inc.

AUPH · CIK 1600620 · Annual (10-K) · Last 6 years

Financial Trends

Revenue$77M
20202025
Net Income$211M
20202025
Operating CF$136M
20202025
Free Cash Flow
20202025

Income Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕
Revenue$0.1B$0.1B$0.0B$0.0B$0.0B$0.1B
Cost of Revenue$0.0B$0.0B$0.0B$0.0B$0.0B—
Gross Profit——————
R&D Expense$0.0B$0.0B$0.0B$0.0B$0.1B$0.1B
SG&A Expense——$0.2B$0.2B$0.2B—
Operating Income$0.0B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B
Net Income$0.2B$0.0B$-0.0B$-0.0B$-0.0B$-0.0B
EPS (Basic)$1.60$0.01$-0.19$-0.18$-0.25—
EPS (Diluted)$1.53$0.01$-0.19$-0.18$-0.25—

Balance Sheet

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕
Total Assets$0.8B$0.6B$0.5B$0.5B$0.5B$0.5B
Current Assets$0.5B$0.4B$0.4B$0.4B$0.5B$0.4B
Cash & Equivalents$0.1B$0.1B$0.0B$0.1B$0.2B$0.3B
Total Liabilities$0.2B$0.2B$0.2B$0.1B$0.1B$0.1B
Current Liabilities$0.1B$0.1B$0.1B$0.0B$0.0B$0.0B
Stockholders' Equity$0.6B$0.4B$0.4B$0.4B$0.5B$0.4B

Cash Flow Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕
Operating Cash Flow$0.1B$0.0B$-0.0B$-0.1B$-0.2B$-0.1B
Investing Cash Flow$-0.0B$0.0B$-0.0B$-0.1B$-0.1B$-0.2B
Capital Expenditures——————
Financing Cash Flow$-0.1B$-0.0B$-0.0B$0.0B$0.2B$0.2B
← Companies